Cargando…
MON-LB82 Plasma Expression Level of MiRNA -21 Is Related With the Presence of Papillary Thyroid Cancer
Introduction.: There is no effective and reliable biomarker to distinguish benign thyroid nodules (BTN) from papillary thyroid carcinomas (PTC). In this study we analyzed a set of four miRNA molecules in plasma of patients with papillary thyroid cancer, benign nodules and healthy controls to identif...
Autores principales: | Zilaitiene, Birute, Kondrotiene, Aiste, Pamedytyte, Daina, Simanaviciene, Vaida, Dauksiene, Dalia, Zvirbliene, Aurelija, Kazokaite, Mintaute, Klimaite, Raimonda, Sarauskas, Valdas, Dauksa, Albertas, Verkauskiene, Rasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208536/ http://dx.doi.org/10.1210/jendso/bvaa046.2132 |
Ejemplares similares
-
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer
por: Kondrotienė, Aistė, et al.
Publicado: (2020) -
Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features
por: Kondrotienė, Aistė, et al.
Publicado: (2021) -
SAT-LB096 Relationship between MicroRNA Expression Levels and Clinicopathological Parameters and Recurrence of Papillary Thyroid Carcinoma
por: Pamedytyte, Daina, et al.
Publicado: (2019) -
Association of microRNA Expression and BRAF(V600E) Mutation with Recurrence of Thyroid Cancer
por: Pamedytyte, Daina, et al.
Publicado: (2020) -
The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)